Varian Medical Systems (VAR) Misses Q2 EPS by 10c, Revenues Beat; Raises FY19 Revenue Guidance & Revenue Growth Rate, Affirms FY19 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. GNK
3. NVDA
4. PLUR
5. SPCX
6. AZN
7. FNGR
8. GSAT
9. S
10. AGPU

Go back to Varian Medical Systems (VAR) Misses Q2 EPS by 10c, Revenues Beat; Raises FY19 Revenue Guidance & Revenue Growth Rate, Affirms FY19 EPS Outlook

Varian Reports Results for Second Quarter of Fiscal Year 2019

April 24, 2019 4:09 PM EDT

PALO ALTO, Calif., April 24, 2019 /PRNewswire/ --

Second Quarter 2019 Summary

    Oncology gross orders grew 15% in dollars, or 18% in constant currency     Total company revenues grew 7% in dollars, or 10% in constant currency, to $779 million     GAAP operating earnings grew 1% at 14.1% of revenues; Non-GAAP operating earnings declined 6% at 15.3% of revenues     GAAP net earnings per diluted share of $0.96; Non-GAAP net earnings per diluted share of $1.05     Recently enacted US/China tariffs negatively impacted revenue growth by $9 million or 120 basis points and GAAP operating earnings growth by $13 million or 160 basis points     Raising revenue growth range for... More